Evidence-based translation of epigenetic testing to increase the precision of prostate cancer risk and prognosis prediction.

  • Southey, Melissa (Primary Chief Investigator (PCI))
  • Giles, Graham G. (Chief Investigator (CI))
  • Dowty, James G (Chief Investigator (CI))
  • Milne, Roger (Chief Investigator (CI))
  • MacInnis, Robert Jeffrey (Chief Investigator (CI))
  • Dugue, Pierre-Antoine (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/10/1930/09/22

Funding

  • Prostate Cancer Foundation of Australia: AUD454,212.00

Keywords

  • prostate cancer
  • risk prediction
  • epigenetics